Ondrej Choutka, MD
Neurological Surgery · Boise, IDNPI 1265651566
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,544 and has fallen 59.4% since, to $627 in 2025.
Across 36 payments — averaging $90.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Myriad Genetic Laboratories, Inc.$484
- Tempus AI, Inc$280
- AstraZeneca$266
- Jazz Pharmaceuticals Inc.$250
- EMD Serono, Inc.$250
- Integra Lifesciences Corporation$238
- plus $2K from 15 others
Across 6 payments — averaging $1829.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GT Medical Technologies, Inc$11K
What the payments were for
- Food & beverage$3,271100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Myriad Genetic Laboratories, Inc. | 4 | $484 |
| Tempus AI, Inc | 4 | $280 |
| AstraZeneca | 3 | $266 |
| Jazz Pharmaceuticals Inc. | 2 | $250 |
| EMD Serono, Inc. | 2 | $250 |
| Integra Lifesciences Corporation | 2 | $238 |
| Microvention, Inc. | 1 | $200 |
| Johnson & Johnson(2 entities) | 3 | $198 |
| Daiichi Sankyo Inc. | 2 | $184 |
| Exelixis Inc. | 1 | $135 |
| CTI Biopharma Corp. | 1 | $132 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Astellas Pharma US Inc | 1 | $121 |
| Medtronic | 1 | $117 |
| Zimmer Biomet | 1 | $105 |
| Baxter Healthcare | 2 | $53 |
| Davol Inc. | 1 | $52 |
| Livanova USA, Inc. | 1 | $23 |
| GT Medical Technologies, Inc | 1 | $20 |
| Aesculap, Inc. | 1 | $19 |
| GE HealthCare | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- myRisk$484
- ZEPZELCA$250
- WEB Aneurysm Embolization System$200
- Cabometyx$135
- Vonjo$132
- CODMAN CERTAS$127
- CUSA CLARITY$127
- DURAGEN$127
- DURASEAL EXACT$127
- CODMAN HAKIM PRECISION VALVE$127
- Erleada$125
- BAVENCIO$125
- OPDIVO$125
- TAGRISSO$125
- Enhertu$125
- PADCEV$121
- FUSION$117
- INSTRUMENTS-ENT$112
- INSTRUMENTS-GENERAL SURGERY$112
- INSTRUMENTS-SURGICAL HEADLIGHTS$112
How this compares
$3,271 in reported general payments places this provider in the 60th percentile of 43 neurological surgery providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurological surgery in Boise
- Donald BlaskiewiczBoise$2.1M
- Paul MontalbanoBoise$27K
- Evan JoyceBoise$25K
- Leonardo BrasilienseBoise$13K
- Graham HallBoise$8K
- David BrayBoise$2K
- Kelly BridgesBoise$2K
- Nicholas GamboaBoise$2K
- Thomas ManningBoise$1K
- Kenneth LittleBoise$900
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.